Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Nalbuphine as an Adjuvant to Levobupivacaine in Subarachnoid Anesthesia in Total Hip Arthroplasty. A Double-blind, Randomized, Controlled Study.

NCT06577155 is registered in ClinicalTrials.gov with Asklepieion Voulas General Hospital as lead sponsor.

NCT NCT06577155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06577155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Nalbuphine as an Adjuvant to Levobupivacaine in Subarachnoid Anesthesia in Total Hip Arthroplasty. A Double-blind, Randomized, Controlled Study.
Lead sponsor
Asklepieion Voulas General Hospital
Phase
Phase 2
Overall status
Completed
Start date
August 29, 2024
Completion date
January 21, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia, total hip arthroplasty